Merck KGaA
MRKPharmaceuticals
€143.30−2.08%As of Oct 23vs prior close
- Market cap
- $20.6B
- P/E (TTM)
- 26.0×
- P/E (FY1)
- 17.0×
- From 52W high
- −2.85%
- EPS (LTM)
- €5.45
- Revenue (LTM)
- €21.1B
- Net margin
- 11.21%
- Dividend yield
- 1.54%
Nomior Score
62
Steady ProfileTop 23% of the scored universe
Growth42
Quality57
Value56
Momentum73
Resilience59
Growth
−1.72%revenue a year over 3 fiscal years
YE22 €22.2BLTM €21.1B
Connections
Revenue to profitYE25
12% of revenue became net profit, down 1 pt on a year.